Skip to main content
. 2023 Dec 28;20(12):855–866. doi: 10.26599/1671-5411.2023.12.005

Table 4. Safety analysis.

Adverse effects SBP < 100 mmHg (n = 47) SBP ≥ 100 mmHg (n = 70) P-value
Permanent discontinuation due to hypotension 3 (6.4%) 4 (5.7%) 1.000
Hyperkalemia 0 0 –
Renal impairment 3 (6.4%) 0 0.062
Angioedema 0 0 –
Stroke 0 2 (2.9%) 0.515